Welcome to our dedicated page for Celestica SEC filings (Ticker: CLS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Celestica Inc. filings document operating results, governance actions, capital-structure matters, and shareholder communications for a Canadian issuer with common shares registered under CLS on the New York Stock Exchange.
Recent disclosures include Form 8-K reports for quarterly and annual financial results, Regulation FD communications, board and committee transitions, annual meeting records, material-event reporting, and share repurchase authorization. The definitive proxy statement covers director elections, executive compensation, shareholder voting procedures, governance policies, and related proxy matters for Celestica’s public-company oversight.
Celestica Inc. reported a Form 4 showing open-market sales of common shares by a trust associated with Chief Executive Officer Robert Mionis. Mionis 2026 GRAT Number Three sold 18,176 common shares on June 17, 2026 at prices between $377.93 and $392.205 per share.
The filing notes these transactions were made under a pre-arranged Rule 10b5-1 trading plan adopted on March 11, 2026. After these transactions, the report shows Mionis with 453,697 common shares held directly and additional indirect holdings of 210,445 and 145,565 common shares in Mionis 2026 GRAT Number One and Number Two, respectively.
Celestica Inc.'s Chief Executive Officer Robert Mionis reported a series of open-market sales of Common Shares on June 16, 2026 by an indirect holding vehicle, Mionis 2026 GRAT Number Three. The filing shows aggregate sales of 55,768 shares at weighted average prices generally between about $381 and $396 per share, executed in multiple trades. These transactions were carried out under a pre-arranged Rule 10b5-1 trading plan. After these sales, the filing also reports continuing holdings of 453,697 Common Shares directly and additional indirect holdings of 210,445 and 145,565 Common Shares through two other 2026 GRAT entities.
Celestica Inc. Chief Executive Officer Robert Mionis reported open-market sales of 66,056 common shares on June 15, 2026. The transactions, carried out by Mionis 2026 GRAT Number Three, were executed under a pre-arranged Rule 10b5-1 trading plan adopted on March 11, 2026.
The shares were sold in multiple trades at prices reported around $394–$414 per share, with each line showing a specific weighted-average price. After these sales, Mionis 2026 GRAT Number Three held 198,964 common shares, while separate filings show indirect holdings of 210,445 shares in Mionis 2026 GRAT Number One, 145,565 shares in Mionis 2026 GRAT Number Two, and a direct holding of 453,697 common shares.
Celestica Inc.’s Chief Financial Officer Mandeep Chawla reported open-market sales of 17,000 Common Shares on June 15, 2026. The Form 4 shows multiple trades at prices between $394.25 and $412.99 per share, executed under a pre-arranged Rule 10b5-1 trading plan adopted on March 13, 2026. After these transactions, Chawla directly owns 99,244 Common Shares of Celestica.
Celestica Inc. reported proposed sales of common shares on a Form 144. The filing lists 9,483 common shares tied to restricted share unit vesting dated 12/01/2025 and 7,517 common shares tied to performance share unit vesting dated 02/02/2026. The notice includes form fields showing 17,000, 6,683,040, 114,973,107, and an exchange label NYSE with a date of 06/15/2026.
CLS filed a Form 144 notice disclosing a proposed sale of 140,000 shares of Common Stock by an affiliate, with an aggregate offering price of $56,000,000.00. The filing lists RSU vesting entries of 2,720 (01/31/2020) and 137,280 (02/02/2026). The broker listed is Fidelity Brokerage Services LLC and the market is NYSE.
Ahuja Kulvinder reported acquisition or exercise transactions in this Form 4 filing.
Celestica Inc. director Kulvinder Ahuja reported equity-based compensation awards, not open-market trades. On May 20, 2026, Ahuja received 567 Director Restricted Share Units (D‑RSUs), each representing a right to one common share or equivalent cash and vesting on the first anniversary of the grant date.
On May 19, 2026, Ahuja was also granted 54 Director Share Units, which each represent a contingent right to receive one common share or equivalent cash when the holder ceases serving Celestica as a director, consultant, or other service provider. These awards increase Ahuja’s deferred and restricted share-based holdings but do not involve any purchase or sale of Celestica common shares in the market.
CASCELLA ROBERT reported acquisition or exercise transactions in this Form 4 filing.
Celestica Inc. director Robert Cascella reported new equity-based compensation awards. On May 19, 2026, he was granted 58 Restricted Share Units (RSUs), each representing a contingent right to receive one common share or equivalent cash, with one-third vesting annually over three years.
On May 20, 2026, he received 619 Director Restricted Share Units (D‑RSUs), vesting on the first anniversary of the grant date. Each D‑RSU represents a contingent right to receive one common share upon settlement or an equivalent cash value. These are compensation grants, not open‑market share purchases or sales.
Colpron Francoise reported acquisition or exercise transactions in this Form 4 filing.
Celestica Inc. director Francoise Colpron received new equity-based awards in the form of restricted share units. On May 19, 2026, Colpron was granted 115 Restricted Share Units (RSUs), each representing a contingent right to one common share or equivalent cash, vesting in three equal annual installments on each anniversary of the grant date.
On May 20, 2026, Colpron was granted 869 Director Restricted Share Units (D‑RSUs), which vest on the first anniversary of the grant date. Each D‑RSU similarly represents a contingent right to receive one common share upon settlement or, at Celestica’s election, an equivalent value in cash. These grants are compensation awards, not open‑market purchases or sales.
Kale Jill reported acquisition or exercise transactions in this Form 4 filing.
Celestica Inc director Jill Kale reported awards of new share-based compensation. On May 19, 2026, she received 108 restricted share units (RSUs), each representing a contingent right to one common share or equivalent cash, with one-third vesting annually over three years.
On May 20, 2026, she was granted 810 director restricted share units (D‑RSUs), which vest on the first anniversary of the grant date. These awards are compensation-related grants, not open‑market purchases or sales of Celestica common shares.